cp wire

CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Eastman, a global specialty ingredient maker is pleased to share that the formulation scientists now have a new tool in their toolbox to formulate poorly water-... read more
Mon, 05/1/23 - 10:29 am
admin
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

This past week, news from Ferring, Pfizer, Novo Nordisk, and Boehringer topped the list of those with the most clicks, as well as a story... read more

Mon, 04/3/23 - 03:26 pm
admin
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CDMO company ... read more
Tue, 03/28/23 - 12:34 pm
admin
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
PharmaBlock (stock code: 300725.SZSE), a global, fully integrated CDMO company focused... read more
Mon, 03/27/23 - 02:10 pm
admin
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

This week, stories from PTC Therapeutics, Novartis, and Novo Nordisk topped our most-read news links, as well as a piece about potential buyers for Baxter’s biopharma solutions business.... read more

Sun, 03/26/23 - 03:36 pm
admin
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

This week, stories from Medtronic, Merck, and Novartis topped our most-read news links, as well as a piece about the compensation for Johnson... read more

Sat, 03/18/23 - 03:34 pm
admin
Klick Health launches new healthcare venture studio
... read more
Thu, 02/16/23 - 04:41 pm
admin
Medtech earnings reports: insights from major players' Q4 results
It's Q4 earnings season, and several medtech firms have reported financials this week, including Edwards Lifesciences, Stryker, Boston Scientific... read more
Thu, 02/2/23 - 01:26 pm
admin
Key compliance issues for medtech firms transitioning to data-enabled solutions
Medtech firms transitioning to data-enabled solutions face a number of compliance issues that need to be... read more
Mon, 01/30/23 - 10:21 am
admin
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine
Novavax has said that it expects its Covid-19 vaccine to remain an important part of the country’s immunization plan, as regulators work to... read more
Sun, 01/29/23 - 02:09 pm
admin
First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

As the second leading infectious killer after COVID-19, tuberculosis (TB) is considered a major worldwide health threat – accounting for nearly two million deaths annually, according to the... read more

Mon, 10/24/22 - 12:55 pm
admin
Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Novartis has signed a deal with the Medicines Patent Pool to allow generic production of its patented drug Tasigna (nilotinib) to treat chronic myeloid leukemia (CML). This landmark agreement... read more

Thu, 10/20/22 - 12:19 pm
admin
Korean firm LG Chem buying AVEO Oncology for $566M

AVEO Oncology has agreed to an acquisition by Korean firm LG Chem for $566M in an all-cash deal. The offering price of $15.00/share represents a 43% premium over AVEO's closing price on Monday,... read more

Tue, 10/18/22 - 01:55 pm
admin
NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
Bend Bioscience, based in Bend, Oregon, to focus on new innovation, product development, and manufacturing.

 

... read more
Mon, 10/17/22 - 10:07 am
admin
RxMx and Curatio Announce Merger to Tackle Urgent Healthcare Gaps

Two global innovators join to support overburdened doctors and isolated patients with award-winning patient-first digital-first technology

Wed, 09/7/22 - 12:31 pm
admin
North America’s Largest lntegrated Research Site Organization, Centricity Research, Expands Further with Addition of Aventiv Research

COLUMBUS, GA; TORONTO, ON; AND COLUMBUS, OH – JUNE 21, 2022 – North America’s clinical research leader, Centricity Research, announced that Aventiv Research has... read more

Wed, 06/22/22 - 10:38 am
admin
AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology
• AbbVie is licensing Sirona's library of skincare compounds, including TFC-1067
• Sirona Biochem's TFC-1067 has been clinically proven to be better than the current 'gold... read more
Mon, 06/13/22 - 12:39 pm
admin
Three Companies Join Forces to Become Centricity Research, North America’s Largest lntegrated Research Site Organization
COLUMBUS, GEORGIA AND TORONTO, ONTARIO — Clinical research leaders IACT Health, LMC Manna Research and True North Clinical Research — which joined forces last month — today... read more
Thu, 01/20/22 - 10:38 am
admin
IACT LMC Manna Research Merges with True North Clinical Research, Boosting the Network’s Central Nervous System Disorder Capabilities

Clinical research leader IACT LMC Manna Research has announced that it has merged with True North Clinical Research Inc., significantly expanding the organization’s services... read more

Mon, 12/20/21 - 12:24 pm
admin
IACT Health and LMC Manna Research Announce Strategic Alliance, Creating One of North America’s Largest Fully Integrated Research Networks

This alliance will  focus on improving service to pharmaceutical and research partners globally and advancing treatment options for patients across all therapeutic areas... read more

Thu, 11/18/21 - 12:23 pm
admin

Pages

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information